Acquired Hemophilia A Associated with NSAID: A Case Report
Keywords:
Acquired Haemophilia, NSAID, inhibitor, factor VIIIAbstract
Acquired hemophilia A (AHA) is a blood clotting disorder caused by the presence of autoantibodies (inhibitors) against factor VIII. The typical symptom of this disorder is bleeding under the skin and soft tissue (rarely in the joints), with no family or personal previous history of bleeding. This case reports is tended to build up awareness for better diagnosis and therapy. Woman, 39 years old, bruises on both forearms are intermittent for 2 months with a history of long term drug consumption for headache treatment. Hemostatic test showed the elongation of activated partial thromboplastin test (APTT) to 87.1 (normal 24.4-44.4 seconds) and the decreament of factor VIII (FVIII) activity to 5% (normal 60-150%). Provision of recombinant factor VIII lowered factor VIII activity to 2%. Factor VIII inhibitor titer was 21.12 BU and diagnosis AHA was made. Inhibitor eradication by methylprednisolone tablet 3x16mg which was given for 2 months, improved the APPT to 46.7 seconds and factor VIII activity to 36%. Acquired Hemophilia A should be suspected in an adult bleeding patient with history of taking a long time non-steroidal anti-inflammatory drugs (NSAIDs). This case is a rare case in Indonesia and therefore the procedure for diagnosis needs to be improved in order to avoid errors in delivering a therapy which can cause the decreament of factor VIII activity.References
Flisinski M, Windyga J, Stefariska E, et al. Acquired hemophilia: a case report. Polskie Archiwum Medycyny Wewnetrznej. 2008;118(4).
Tirunagari S, Shaik D. Hemophilia & Acquired Hemophilia A. Webmed Central CLINICAL TRIALS 2013;4(3):WMC004048.
Stefanacci RG. Acquired inhibitors: A special case of bleeding in older adults. Curr Gerontol Geriatric Res. 2012;308109:5. doi:10.1155/2012/308109.
Shah G, Kandra A, Drelich D. Acquired hemophila A: A case report. Med Forum. 2011;11:7.
Freire M, Teodoro RB, Nogueira DA, et al. Acquired hemophilia associated with rheumatoid arthritis. Bras J Rheumatol. 2009;49(3):302-7.
Giangrande P. Acquired hemophilia. Revised edition. Treatment of hemophilia. World Fed Hemophilia. 2012:38.
Ma AD, Carrizosa D. Acquired factor VIII inhibitors: Pathophysiology and treatment. Am Soc Hematol. 2006:432-7.
Lee JJ, Chung IJ, Park MR, et al. Acquired hemophilia successfully treated with oral immunosuppressive therapy. Korean J Intern Med. 2000;15:2.
Collins P, Baudo F, Huth-Kuhne A, et al. Consensus recommendation for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010;3:161.
Sakurai Y, Takeda T. Acquired hemophilia A: A frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res. 2014;320674.
Tufano A, Coppola A, Guida A. Acquired haemophilia A in the elderly: Case reports. Curr Gerontol Geriatric Res. 2010;927503.
Pathirana UGP, Gunawardena N, Abeysinghe H, et al. Acquired hemophilia A associated with autoimmune thyroiditis: A case report. J Med Case Reports. 2014;8:469.
Orlova NA, Kovnin I, Vorobiev I. Blood clotting factor VIII: From evolution to therapy. Acta Naturae. 2013;5 (17):2013.
Tanaka TN, Sohda S, Someya K. Acquired haemophilia due to factor VIII inhibitors in ovarian hyperstimulation syndrome: Case report. Human Reproduction. 2003:18(3):506-8.
Murray NP, Moncada JC, Moran M. Duodenal tumor presenting as acquired hemophilia in an 88-year-old woman: A clinical case and review of literature. Case Reports in Gastrointestinal Medicine. 2012;203801.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
